Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 348

2.
4.

Protection against Leishmania major infection by oligomannose-coated liposomes.

Shimizu Y, Yamakami K, Gomi T, Nakata M, Asanuma H, Tadakuma T, Kojima N.

Bioorg Med Chem. 2003 Apr 3;11(7):1191-5.

PMID:
12628646
7.

Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.

Ishii M, Koyama A, Iseki H, Narumi H, Yokoyama N, Kojima N.

Int Immunopharmacol. 2010 Sep;10(9):1041-6. doi: 10.1016/j.intimp.2010.06.003. Epub 2010 Jun 11.

PMID:
20584630
8.

Leishmania major: immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes.

Badiee A, Jaafari MR, Khamesipour A.

Exp Parasitol. 2007 Feb;115(2):127-34. Epub 2006 Sep 18.

PMID:
16979165
9.
10.

ISCOMs vaccine against experimental leishmaniasis.

Papadopoulou G, Karagouni E, Dotsika E.

Vaccine. 1998 May-Jun;16(9-10):885-92.

PMID:
9682333
11.

Cysteine proteinase type I, encapsulated in solid lipid nanoparticles induces substantial protection against Leishmania major infection in C57BL/6 mice.

Doroud D, Zahedifard F, Vatanara A, Najafabadi AR, Rafati S.

Parasite Immunol. 2011 Jun;33(6):335-48. doi: 10.1111/j.1365-3024.2011.01289.x.

12.
13.

Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.

Sharma SK, Dube A, Nadeem A, Khan S, Saleem I, Garg R, Mohammad O.

Vaccine. 2006 Mar 10;24(11):1800-10. Epub 2005 Oct 28.

PMID:
16310900
14.

The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).

Badiee A, Jaafari MR, Khamesipour A, Samiei A, Soroush D, Kheiri MT, Barkhordari F, McMaster WR, Mahboudi F.

Exp Parasitol. 2009 Apr;121(4):362-9. doi: 10.1016/j.exppara.2008.12.015. Epub 2009 Jan 1.

PMID:
19211022
15.
16.
17.

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

Afonso LC, Scharton TM, Vieira LQ, Wysocka M, Trinchieri G, Scott P.

Science. 1994 Jan 14;263(5144):235-7.

PMID:
7904381
18.

Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.

Jaafari MR, Ghafarian A, Farrokh-Gisour A, Samiei A, Kheiri MT, Mahboudi F, Barkhordari F, Khamesipour A, McMaster WR.

Vaccine. 2006 Jul 17;24(29-30):5708-17. Epub 2006 May 11.

PMID:
16740346
19.
20.

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

Zadeh-Vakili A, Taheri T, Taslimi Y, Doustdari F, Salmanian AH, Rafati S.

Vaccine. 2004 May 7;22(15-16):1930-40.

PMID:
15121305

Supplemental Content

Support Center